Evaluation of antibacterial activity and the mechanism of naringenin against Mycoplasma synoviae
Year: 2026
Type: article
Abstract: The global antibiotic resistance crisis has fueled a demand for promising novel alternatives. Naringenin, a type of traditional Chinese medicine, is known for its anti-tumor, anti-inflammatory, and antibacterial activities. However, the inhibitory effect of naringenin on Mycoplasma has not yet been established. Herein, we reported that naringenin effectively inhibited various mycoplasmas. Using Mycoplasma synoviae ( M. synoviae ) as a model, naringenin inhibited cell growth, biofilm formation, cell division, and increased reactive oxygen species (ROS) production. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of naringenin against M. synoviae was identified as 125 and 250 µg/mL, respectively. Dose-dependent inhibition effect of naringenin on the growth of M. synoviae . The anti-biofilm effect of naringenin was confirmed using crystal violet staining and laser confocal microscopy. Scanning electron microscopy showed that both cell length and width were significantly reduced, and the length/width ratio was significantly increased, indicating that cell morphology changed from spherical to rod-shaped upon treatment with naringenin. RT-qPCR analysis showed a significant reduction in the expression of genes involved in biofilm formation ( eno , gap , and pdhD ) and cell division ( ftsZ , stk , ftsH , and wihA ) after culturing with 1/2×MIC of naringenin. Another possible anti-mycoplasma mechanism is that naringenin markedly increased intracellular ROS levels and significantly reduced SOD activity, whereas POD, CAT, and GSH were not significantly affected. Collectively, these results demonstrate that naringenin exerts anti-mycoplasma effects by inhibiting M. synoviae cell growth, biofilm formation, and cell division, while simultaneously inducing oxidative damage.
Authors: Qiao Hu(Funding acquisition, Investigation, Project administration, Writing – original draft, Writing – review & editing), Qin Lu, Yunqing Guo(Funding acquisition, Methodology, Validation, Writing – review & editing), Xiaoyi Cao(Formal analysis, Validation, Writing – original draft), Jiaying Liu(Conceptualization, Visualization, Writing – original draft), Wenting Zhang(Investigation, Methodology, Writing – review & editing), Rongrong Zhang(Conceptualization, Methodology, Writing – review & editing), Bokai Yang(Formal analysis, Software, Writing – original draft), Peipei Zheng(Methodology, Validation, Writing – review & editing), Ping Zhou(Methodology, Validation, Writing – review & editing), Tengfei Zhang(Data curation, Visualization, Writing – original draft, Writing – review & editing), Qingping Luo(Funding acquisition, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236473963
